Bristol-Myers, Nektar Team Up To Develop Immunotherapy Drug
The deal is the latest in a long list of collaborations between companies to find the right combinations of anti-cancer drugs for the right patients.
San Francisco Business Times:
Big Pharma Partners With Another Bay Area Company In Cancer Immunotherapy Quest
Bristol-Myers Squibb Co. will test its groundbreaking cancer immunotherapy drug Opdivo with an experimental cancer-fighting drug from Nektar Therapeutics Inc., the companies said Tuesday. (Leuty, 9/27)